Supplementary Figure 3: Isogenic cell line assessment and properties. (A)
Western blot quantifying BAP1 expression in NCI-H226 and QR isogenic cell lines. β-actin is used as loading control. (B) Sanger sequencing of BAP1 coding sequence to illustrate single nucleotide change from wild-type TGT into AGT to generate the C91S catalytically inactivating mutation in NCI-H226 cell line. (C) Proliferation curves of NCI-H226 isogenic cell lines performed during 7 days. Differences start to be significant at day 7 post-seeding. Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 versus Empty Vector (EV). EV, BAP1 wt , BAP1 C91S : NCI-H226 or QR transfected with empty, wild-type BAP1 and deubiquitinase dead BAP1 vectors, respectively. NCI-H226 transfected with empty and wild-type BAP1, respectively. 3 reagents (10 mM glucose , 30 μM oligomycin A , 100 mM 2-DG) which are serially injected to non-glycolytic acidification, glycolysis, and glycolytic reserve, respectively.(i.e. injections). (B and C) Bar graphs are quantifications of glycolytic capacity and glycolytic reserve measurements, respectively (i.e. maximal glycolysis minus basal glycolysis and maximal glycolysis minus no glycolysis). EV, BAP1
wt :
NCI-H226 transfected with empty, wild-type BAP1 and deubiquitinase dead BAP1 vectors, respectively. wt , BAP1 C91S : NCI-H226 transfected with empty, wild-type BAP1 and deubiquitinase dead BAP1 vectors, respectively.
